| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 05/31/1989 | EP0317804A2 HIV peptides and methods for detection of HIV |
| 05/31/1989 | CN1033184A Process for selective splitting fused protein |
| 05/30/1989 | US4834973 Immunological methods for treating mammals |
| 05/30/1989 | CA1254846A1 Monoclonal antibodies against melanocytes and melanomas |
| 05/24/1989 | EP0316748A2 Process for the selective cleavage of fusion proteins |
| 05/24/1989 | EP0316695A1 Recombinant HIV-2 polypeptides |
| 05/24/1989 | EP0316425A1 A SV40 EXPRESSION VECTOR CONTAINING HBxAg AS AN EXPRESSION MARKER |
| 05/24/1989 | CN1033073A Method for promoting intramolecular bond fisulfide bormation in recombinant proteins contained in denaturant solution |
| 05/23/1989 | US4833074 Purified human granylocyte L1 proteins methods for their preparation, monospecific antibodies and test kits |
| 05/23/1989 | US4833071 Peptide composition as anitgen for detection of antibodies to HTLV-I, as a vaccine for ATL and methods therefor |
| 05/18/1989 | WO1989004491A1 Urinary assay for measuring bone resorption |
| 05/18/1989 | WO1989004486A1 Diagnostic methods and systems for quantifying apo ai |
| 05/18/1989 | WO1989004324A1 Phosphoryled derivatives of cardiodilatine/anf peptides |
| 05/18/1989 | DE3737917A1 Phosphorylierte derivate von cardiodilatin/anf-peptiden Phosphorylated derivatives of cardiodilatin / anf-peptides |
| 05/16/1989 | CA1254161A1 Herpes virus specific immunological materials and methods |
| 05/10/1989 | EP0315456A2 Polysaccharide-modified immunoglobulins having reduced immunogenic potential or improved pharmacokinetics |
| 05/10/1989 | EP0315085A2 Recombinant histidine-rich protein from Plasmodium falciparum, its synthesis and use |
| 05/10/1989 | EP0314862A1 Immunogenic conjugates comprising cyclosporins |
| 05/10/1989 | EP0314861A1 Labeled derivatives of cyclosporins |
| 05/09/1989 | US4828988 Hybrid polypeptides comprising somatocrinine and alpha1 -antitrypsin, method for their production from bacterial clones and use thereof for the production of somatocrinine |
| 05/05/1989 | WO1989003849A1 Oligonucleotide-polyamide conjugates |
| 05/05/1989 | WO1989003845A1 Ps2 protein derivative |
| 05/05/1989 | WO1989003687A1 Composition and method for treating cancers characterized by over-expression of the c-fms proto-oncogene |
| 05/03/1989 | EP0314317A1 Adheson variants, nucleic acid encoding them and compositions comprising them |
| 04/25/1989 | US4824659 Antibody conjugates |
| 04/20/1989 | WO1989003532A1 Means for diagnosing arc and aids |
| 04/20/1989 | WO1989001783A3 Recombinant antibody and method |
| 04/19/1989 | EP0312358A2 Method for promoting intramolecular disulfide bond formation in recombinant proteins contained in a denaturant solution |
| 04/19/1989 | EP0311675A1 Immunotherapeutic methods and compositions |
| 04/18/1989 | CA1252948A1 Process for purifying proteins |
| 04/12/1989 | EP0311228A2 Recombinant polypeptides and their uses, including assay for AIDS virus |
| 04/11/1989 | US4820633 Process for production of an immune reactive, porous carrier material for heterogeneous immunological analysis |
| 04/06/1989 | WO1989002935A1 Respiratory syncytial virus: vaccines and diagnostic assays |
| 04/06/1989 | WO1989002922A1 Adheson variants |
| 04/06/1989 | WO1989001490A3 Biologically active molecules |
| 04/05/1989 | EP0310137A2 BAR1 secretion signal |
| 04/05/1989 | EP0310136A2 Macrophage-derived inflammatory mediator (MIP-1alpha and MIP-1beta) |
| 04/05/1989 | EP0309746A1 Antimalaria vaccines |
| 04/05/1989 | EP0309555A1 Immunogenic polypeptide and method for purifying it |
| 04/04/1989 | US4818688 Assays for antibody to hepatitis B core antigen |
| 04/04/1989 | US4818684 Immunoassay; binding antibody to steroid complex |
| 04/04/1989 | CA1252046A1 Methods for oncogenic detection |
| 03/30/1989 | DE3731874A1 Verfahren zur herstellung von peptiden durch spezifische spaltung von gentechnisch gewonnenen fusionsproteinen mit collagenasen Process for the preparation of peptides by specific cleavage of fusion proteins with genetically acquired collage noses |
| 03/29/1989 | EP0308936A2 Antibody heteroconjugates for the killing of HIV-infected cells |
| 03/28/1989 | US4816567 Immunology, vectors, dna |
| 03/28/1989 | US4816397 Genetic engineering |
| 03/23/1989 | WO1989002461A1 Process for producing peptides by specific cleavage of fusion proteins with collagenases obtained by genetic engineering |
| 03/22/1989 | EP0308378A2 Tumor necrosis factor (TNF)inhibitory protein and its purification |
| 03/21/1989 | US4813924 Drugs, haptens, antigens, antibodies |
| 03/15/1989 | EP0306680A2 Monoclonal antibodies to anti-thrombin binding substance, and their uses |
| 03/09/1989 | WO1989001974A1 Recombinant antibody |
| 03/09/1989 | WO1989001943A1 Peptide complexes having enhanced stability |
| 03/09/1989 | WO1989001940A1 Dna sequences, recombinant dna molecules and processes for producing soluble t4 proteins |
| 03/09/1989 | WO1989001783A2 Recombinant antibody and method |
| 03/09/1989 | WO1989001782A1 Recombinant antibody |
| 03/08/1989 | EP0306473A1 Pharmaceutical structure with protein-supported agents |
| 03/08/1989 | EP0306219A2 Novel HIV proteins and peptides useful in the diagnosis, prophylaxis or therapy of AIDS |
| 03/08/1989 | EP0305967A2 Conjugates of interferon alpha with immunoglobulins |
| 03/08/1989 | EP0305777A2 Synthesis of human immunodeficiency virus type 1 antigens and their use as diagnostic and therapeutic agents |
| 03/08/1989 | EP0305760A2 Method of isolating basic proteins from a protein mixture |
| 03/08/1989 | EP0305500A1 Process for the purification of recombinant polypeptides. |
| 03/07/1989 | US4810491 Polypeptides useful in vaccination against enteroviruses |
| 03/01/1989 | EP0305229A1 Viral vector and recombinant DNA encoding one or more structural proteins (HA,F and/or NP) of a morbillivirus |
| 02/28/1989 | US4808536 Human t-cell lymphotropic virus; acquired immunodeficiency syndrome; in kit form; screening |
| 02/23/1989 | WO1989001629A1 Human ovarian tumor-associated antigen specific for monoclonal antibody ov-tl3 |
| 02/23/1989 | WO1989001494A1 Hiv-1-related polypeptides, diagnostic systems and assay methods |
| 02/23/1989 | WO1989001490A2 Biologically active molecules |
| 02/22/1989 | EP0304292A2 Antibody to propeptide of procollagen type III, and assay method using it |
| 02/22/1989 | EP0303983A2 Synthetic peptides, antibodies directed against them and their use |
| 02/15/1989 | EP0303488A2 Biologically active molecules |
| 02/14/1989 | CA1250100A1 Pre-s gene coded peptide hepatitis b immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers |
| 02/09/1989 | WO1989001159A1 Receptor membranes |
| 02/09/1989 | WO1989001041A1 Nucleic acid and methods for the synthesis of novel fusion polypeptides with a phospholipid anchor domain |
| 02/09/1989 | WO1989001040A1 Attenuated herpes viruses, herpes viruses which include foreign dna encoding an amino acid sequence and vaccines containing same |
| 02/09/1989 | WO1989000999A1 Modular assembly of antibody genes, antibodies prepared thereby and use |
| 02/09/1989 | WO1988009181A3 Monoclonal antibodies neutralizing hiv-1 |
| 02/08/1989 | EP0302445A2 A novel hypoglycemic and growth-promoting agent |
| 02/07/1989 | US4803155 Monoclonal antibodies to Sclerotinia homoeocarpa |
| 02/07/1989 | CA1249811A1 Rigid coupling compounds |
| 02/01/1989 | EP0302011A2 Monoclonal antibodies and process for the diagnosis of phytophtora infections |
| 02/01/1989 | EP0301485A1 Expression vectors and processes using same in the production of cro/beta-galactosidase/PTH fusion proteins and of PTH |
| 02/01/1989 | EP0138948B1 Dna sequence encoding an exo-signal |
| 01/31/1989 | US4801578 Muramylpeptide-glycoprotein immunostimulant derivatives, their preparation and their use in medication |
| 01/31/1989 | US4801575 Chimeric peptides for neuropeptide delivery through the blood-brain barrier |
| 01/26/1989 | WO1989000166A3 Growth hormone related peptide |
| 01/26/1989 | WO1988007576A3 Vascular anticoagulant proteins, dnas which code for them, manufacture and application thereof |
| 01/25/1989 | EP0300487A2 Enzymatically inactive, immunologically active beta-galactosidase muteins |
| 01/25/1989 | EP0300213A1 Hepatitis a viral peptide particle immunogens |
| 01/25/1989 | EP0300031A1 Immunosuppressive peptides and methods of use |
| 01/25/1989 | EP0299965A1 Antigenic analogues of platelet activating factor (paf) |
| 01/25/1989 | CN1030645A Immunodiagnostic assays using chimeric antigens |
| 01/25/1989 | CN1030589A Urinary follicle stimulating hormone |
| 01/24/1989 | CA1249222A1 Antibody compositions of therapeutic agents having an extended serum half-life |
| 01/18/1989 | EP0299354A2 Monoclonal antibodies against protein E7 of the human papilloma virus type 16, their production process and their use |
| 01/18/1989 | EP0299242A2 Heterologous viral peptide particle immunogens |
| 01/17/1989 | CA1248894A1 Synthetic peptide-based anti-rabies compositions and methods |
| 01/12/1989 | WO1989000166A2 Growth hormone related peptide |
| 01/12/1989 | WO1989000051A1 Fibrin-binding compound and method |
| 01/11/1989 | EP0298654A2 Use of antibody/antigen interactions to protect or modulate biological activity |
| 01/11/1989 | EP0298210A2 Method for the selective immunological determination of intact procollagen peptide (type III) and procollagen (type III) in body fluids and reagents used therefor |